Daniel T Claiborne

10PUBLICATIONS
88CO-AUTHORS
Agricultural molecular engineering of nucleic acids and proteinsMolecular targetsHaematologyPredictive and prognostic markersInnate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Sep 10, 2025
Replication-competent adenovirus reporters utilizing endogenous viral expression architecture.

Claire M O'Brien, Lorenzo Serra, Molly R Patterson

|Jul 14, 2025
Selective Alanine Transporter Utilization Is a Therapeutic Vulnerability in ARID1A-Mutant Ovarian Cancer.

Hao Nie, Liping Liao, Rafal J Zielinski

|Jan 08, 2025
High frequency CCR5 editing in human hematopoietic stem progenitor cells protects xenograft mice from HIV infection.

Daniel T Claiborne, Zachary Detwiler, Steffen S Docken

|Nov 21, 2024
Myeloid activation clears ascites and reveals IL27-dependent regression of metastatic ovarian cancer.

Brennah Murphy, Taito Miyamoto, Bryan S Manning

|Apr 02, 2024
Targeting branched N-glycans and fucosylation sensitizes ovarian tumors to immune checkpoint blockade.

Hao Nie, Pratima Saini, Taito Miyamoto

|Feb 27, 2024
A VRC13-like bNAb response is associated with complex escape pathways in HIV-1 envelope.

Vinita R Joshi, Daniel T Claiborne, Melissa L Pack

Pageof 2